SNDX icon

Syndax Pharmaceuticals
SNDX

Overview Fund Activity

177 hedge funds and large institutions have $1.95B invested in Syndax Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 42 reducing their positions, and 34 closing their positions.

Holders
177
Holders Change
+2
Holders Change %
+1.14%
% of All Funds
2.6%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
36
Increased
82
Reduced
42
Closed
34
Calls
$15.7M
Puts
$14.9M
Net Calls
+$819K
Net Calls Change
+$2.22M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$71.9M
2
KCM
2
Kynam Capital Management
New Jersey
$122M
3
BI
3
BVF Inc
California
$40.5M
4
ACA
4
Avoro Capital Advisors
New York
$91.2M
5
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$58.6M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$1.1M
2
PHS
2
PFM Health Sciences
California
$12.9M
3
PBA
3
Paradigm Biocapital Advisors
New York
$0
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$0
5
CC
5
Commodore Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$164M 7,585,221 -57,225 -0.7%
BlackRock
2
BlackRock
New York
$152M 7,015,548 +1,132,912 +19%
KCM
3
Kynam Capital Management
New Jersey
$122M 5,660,000 +2,060,000 +57%
State Street
4
State Street
Massachusetts
$108M 5,016,224 +1,415,576 +39%
Vanguard Group
5
Vanguard Group
Pennsylvania
$93.7M 4,335,353 +718,051 +20%
ACA
6
Avoro Capital Advisors
New York
$91.2M 4,222,222 +1,666,667 +65%
APM
7
Avidity Partners Management
Texas
$85.4M 3,950,000 +1,129,000 +40%
EP
8
Eversept Partners
New York
$73.1M 3,383,244 +786,999 +30%
Morgan Stanley
9
Morgan Stanley
New York
$71.9M 3,328,612 +2,778,583 +505%
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$61.3M 2,834,499 +740,298 +35%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$58.6M 2,711,253 +1,644,705 +154%
Marshall Wace
12
Marshall Wace
United Kingdom
$45.4M 2,101,911 +1,497,949 +248%
BI
13
BVF Inc
California
$40.5M 1,875,000 +1,875,000 New
O
14
OrbiMed
New York
$37.8M 1,749,000 +465,000 +36%
WP
15
Woodline Partners
California
$33.4M 1,544,216 +1,510,149 +4,433%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$33.2M 1,535,055 +174,135 +13%
Franklin Resources
17
Franklin Resources
California
$29.2M 1,352,905 +1,352,905 New
Goldman Sachs
18
Goldman Sachs
New York
$27M 1,250,948 -16,800 -1%
CAM
19
Cormorant Asset Management
Massachusetts
$25.4M 1,175,000 +1,175,000 New
SC
20
Stempoint Capital
New York
$23.7M 1,094,494 +1,094,494 New
SI
21
Sofinnova Investments
California
$23.2M 1,075,786 +133,969 +14%
ACM
22
Aisling Capital Management
New York
$22.2M 1,025,000 – –
CS
23
Candriam SCA
Luxembourg
$22.1M 1,021,032 +781,022 +325%
Bank of America
24
Bank of America
North Carolina
$21.3M 984,258 +724,400 +279%
Millennium Management
25
Millennium Management
New York
$20.4M 942,642 +502,872 +114%
1
2 3 4 5